B cell lymphokines in human systemic lupus erythematosus

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by B cell hyperactivity.
• The role of lymphokines in mediating B cell responses in SLE requires further elucidation.

Purpose of the Study:

• To investigate whether B lymphocytes from SLE patients exhibit intrinsic hyperresponsiveness to various lymphokine mediators.
• To assess the impact of specific recombinant lymphokines on B cell proliferation and immunoglobulin production in SLE.

Main Methods:

• Peripheral blood B cells from 25 SLE patients and 16 healthy controls were cultured with recombinant interleukins (IL-1, IL-2, IL-4) and other lymphokines.
• Proliferative responses were measured by [3H]thymidine uptake, with and without Staphylococcus aureus Cowan I as a costimulant.
• In vitro IgG and IgM production was assessed in the absence of T cells.
• Lymphokine gene expression (IL-2, IL-3, IL-4) was analyzed using gene probes.

Main Results:

• B cells from both SLE patients and normal subjects did not show increased proliferation in response to IL-1, IL-2, and IL-4.
• Costimulation with Staphylococcus aureus Cowan I enhanced [3H]thymidine uptake in B cells from both groups.
• Recombinant lymphokines did not augment in vitro IgG or IgM production by lupus or normal B cells.
• No spontaneous expression of IL-2, IL-3, or IL-4 genes was detected in circulating lymphocytes.

Conclusions:

• B cells from patients with inactive SLE do not appear to be intrinsically hyperresponsive to the tested recombinant lymphokines.
• The study suggests that lymphokine-mediated B cell hyperactivity may not be a significant factor in inactive lupus disease.
• Further research is needed to explore other potential mechanisms driving B cell abnormalities in SLE.